RecruitingNot ApplicableNCT07448558
Tailored Exercise to Reduce Aromatase Inhibitor Associated Musculoskeletal Symptoms
Effectiveness of Tailored Home-based Exercise on Aromatase Inhibitor-associated Musculoskeletal Symptoms in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitor: A Randomized, Controlled Trial
Sponsor
Mahidol University
Enrollment
206 participants
Start Date
Feb 18, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
A randomized controlled study evaluating effect of tailored exercise compared to routine practice as a preventive measure of aromatase inhibitor associated musculoskeletal related symptoms in early breast cancer patients
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- breast cancer patients with starting adjuvant aromatase inhibitor within 4 weeks
- able to read and write
Exclusion Criteria3
- chronic arthritis
- history of heart failure or acute coronary syndrome within 6 months
- individuals who exercises regularly more than 150 minutes/week
Interventions
BEHAVIORALtailored exercise
tailored suitable exercise to individuals recommended for the aim of aerobic exercise at 150 minutes per week and strengthening exercise twice a week
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07448558